文献速递头颈外科

大麻使用与头颈游离皮瓣重建术后阿片类药物长期使用

Cannabis Use and Prolonged Opioid Utilization After Head and Neck Free Flap Reconstructive Surgery.
PubMed 文献 · Laryngoscope · 2026-10-16

本研究基于TriNetX数据库(2005-2025)纳入头颈游离皮瓣重建患者,按大麻使用分层并行倾向评分匹配,每组532例。大麻使用者在术后3-12个月各时段阿片类药物长期使用风险均升高,且3个月胃造瘘管依赖风险更高,调整行为健康合并症后关联仍独立存在。

要点

  • 术前大麻使用与术后3-12个月阿片类药物长期使用风险升高相关
  • 大麻使用者术后3个月胃造瘘管依赖风险升高(RR 1.56)
  • 气管造瘘依赖在各时间点无显著差异

核心结论

  • 有大麻使用史的头颈癌患者游离皮瓣重建术后长期阿片类药物使用风险升高,调整行为健康合并症后仍独立相关。
  • 需针对该人群制定疼痛管理策略并加强术后监测。

研究设计与样本

  • 回顾性队列研究,使用TriNetX数据库纳入2005-2025年头颈游离皮瓣重建患者。
  • 按大麻使用分层,倾向评分匹配人口学、物质使用和肿瘤特征,匹配后每组532例。
  • 主要结局为术后3-12个月阿片类药物使用,次要结局为气管造瘘和胃造瘘依赖。
  • 采用多变量Cox回归调整行为健康合并症。

主要发现

  • 大麻使用者术后3个月胃造瘘管依赖风险升高(RR 1.56,95% CI [1.19-2.04])。
  • 术前大麻使用增加术后3-6个月阿片类药物长期使用风险(RR 1.19,95% CI [1.05-1.36])。
  • 术前大麻使用增加术后6-9个月阿片类药物长期使用风险(RR 1.35,95% CI [1.13-1.62])。
  • 术前大麻使用增加术后9-12个月阿片类药物长期使用风险(RR 1.26,95% CI [1.04-1.52])。
  • 调整Cox回归显示围术期大麻使用与长期阿片类药物使用独立相关(HR 1.42,90% CI [1.14, 1.76])。

临床怎么用

  • 对有大麻使用史的头颈游离皮瓣重建患者,应制定针对性疼痛管理策略并加强术后阿片类药物使用监测。
  • 关注大麻使用者术后胃造瘘管依赖风险,做好营养支持与康复规划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

GOAL: This study investigates the risk of prolonged postoperative opioid use and functional outcomes of free flap reconstruction in head and neck cancer patients with a history of cannabis use. METHODS: Patients undergoing head and neck free flap reconstruction (2005-2025) were identified using the TriNetX database and stratified by cannabis use. Cohorts were propensity score-matched for demographics, substance use, and tumor characteristics. The primary outcome was postoperative opioid use at 3-12 months; secondary outcomes included tracheostomy and gastrostomy dependence. Multivariable Cox regression adjusted for behavioral health comorbidities. RESULTS: After matching, each cohort (cannabis users and non-users) consisted of 532 patients. Cannabis users were more likely to be gastrostomy tube dependent at 3 months (RR: 1.56, 95% CI: [1.19-2.04]). Preoperative cannabis use increased the risk of prolonged postoperative opioid use at 3-6 months (RR: 1.19, 95% CI: [1.05-1.36]), 6-9 months (RR: 1.35, 95% CI: [1.13-1.62]), and 9-12 months (RR: 1.26, 95% CI: [1.04-1.52]). There was no significant difference in tracheostomy dependence at any time point. In adjusted Cox regression analysis, perioperative cannabis persisted as independently associated with prolonged opioid use (HR: 1.42, 90% CI: [1.14, 1.76]). CONCLUSION: Head and neck cancer patients with a history of cannabis use demonstrate increased risk of prolonged opioid use after free flap reconstructive surgery even after adjusting for behavioral health comorbidities, highlighting the need for targeted pain management strategies and closer postoperative monitoring in this patient population.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Jackert EP, Gallagher T, Gamero M, et al. Cannabis Use and Prolonged Opioid Utilization After Head and Neck Free Flap Reconstructive Surgery. Laryngoscope. 2026. PMID: 42888518. doi:10.1002/lary.71002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。